HOME >> BIOLOGY >> NEWS
Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies

TROY, N.Y. World-renowned biotechnology experts and science policymakers will join the Rensselaer Polytechnic Institute community at a series of events Sept. 9-11, including a symposium, Presidential Colloquy, ribbon-cutting, a play, and an open house to mark the opening of the Institute's Center for Biotechnology and Interdisciplinary Studies.

On Thursday, Sept. 9, Rensselaer will host a biotechnology symposium that will begin with keynote addresses from:

  • Shirley Tilghman, Ph.D., President and Professor of Molecular Biology, Princeton University, on "The Human Genome Decoded: Promises Kept and Promises To Come"

  • Robert S. Langer, Sc.D., Kenneth J. Germeshausen Professor of Chemical and Biomedical Engineering, Massachusetts Institute of Technology, on "Biomaterials and How They Will Change Our Lives"

  • Troy Duster, Ph.D., Professor of Sociology, New York University, and Chancellor's Professor, University of California, Berkeley, on "The Role of Molecular Biology in the New Uses of Race in Science, Medicine, and Law"

On Friday, Sept. 10, Rensselaer President Shirley Ann Jackson will host a Presidential Colloquy on "Opportunities at the Interface of Bioscience and Bioengineering" with:

  • The Honorable Elias Zerhouni, M.D., Director, National Institutes of Health

  • Bruce Alberts, Ph.D., President, National Academy of Sciences

  • William Wulf, Ph.D., President, National Academy of Engineering

  • Claire M. Fraser '77, Ph.D., President and Director, Investigator, The Institute for Genomic Research

  • James C. Mullen '80, President and CEO, Biogen Idec Inc.

  • William A. Haseltine, Ph.D., Chairman and Chief Executive Officer, Human Genome Sciences Inc.

A ribbon-cutting ceremony, lead by President Jackson, will follow the colloquy. Speakers will include:

  • The Honorable Hillary Clinton, United States Senator (N.Y.)

  • The Honorable Michael McNulty, Unit
    '"/>


Contact: Theresa Bourgeois
bourgt@rpi.edu
518-276-2840
Rensselaer Polytechnic Institute
2-Sep-2004


Page: 1 2 3 4

Related biology news :

1. Rensselaer receives NIH grant to develop virtual surgery simulator
2. New software developed at Rensselaer predicts promising ingredients for new drugs
3. Rensselaer awarded $2.7 million NIH grant to improve drug development process
4. National Institutes of Health grant to Rensselaer to further research on healing bone injuries
5. Kimberly-Clark Worldwide donates intellectual property to Rensselaer
6. Rensselaer effort to pull mussels at Lake George looks promising
7. NASA Funds New Origin Of Life Center at Rensselaer Polytechnic Institute
8. X marks the spot: Vector insertion is viral specific
9. Despite darkness, nocturnal bees learn visual landmarks while foraging at night
10. High Flux Isotope Reactor marks 400th cycle
11. Study marks increased trends in infectious disease occurrences in our oceans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... June 04, 2020 , ... Greffex, a pioneering vaccine and ... of Directors. , “Neil understands the need for a global perspective to make an ... of Greffex. Mr. Bush will serve as an independent, director of the company. , ...
(Date:5/28/2020)... ... May 27, 2020 , ... Today bioinformatics leader hc1® ... uniquely combines lab testing insights and hc1’s exclusive Local Risk Index in a ... safety of employees returning to the workplace. , “Some of the best ways ...
(Date:5/25/2020)... ... May 22, 2020 , ... Oxford Nanopore Technologies is in advanced development of ... that causes COVID-19. , The LamPORE assay is designed to be rapid, ... very large numbers of samples. Hardware and reagents sit outside current, squeezed supply ...
Breaking Biology News(10 mins):
(Date:7/7/2020)... ... July 06, 2020 , ... Bio-IT World has announced ... Bristol-Myers Squibb, the University of Chicago, Massachusetts General Hospital, Mission: Cure, and the ... awards program, highlighting outstanding examples of how technology innovations and strategic initiatives can ...
(Date:7/1/2020)... ... June 30, 2020 , ... ... insights, today announced that the launch of a new clinical diagnostics ... about the tumor microenvironment (TME). , “Flagship’s TissueInsight is a service that ...
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... complex indoor environments, announced today that Derek Fournier has been appointed CEO and ... of the Board, effective immediately. , “DeCurtis Corporation has been on an ...
Breaking Biology Technology:
Cached News: